BMRN
#851
BioMarin Pharmaceutical Inc. - Common Stock
58.6 4 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.95%
Variación mensual
+4.56%
Variación en los últimos 6 meses
+4.29%
Cambio anual
+0.07%
Cierres anteriores
59.2 0
Open
58.4 7
Mínimo
58.2 4
High
58.6 6
Volumen
195
Financials
- Market Capitalization 11.33 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
33.02
Relación precio/flujo de caja
3.64
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 819 |  SMMT Summit Therapeutics Inc. - Common Stock | 15.57 USD | +1.76% | -1.27% | +7.83% | -21.60% | 12.08 B USD | ||
| 827 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 233.73 USD | +2.39% | -5.10% | -8.10% | +79.52% | 12.03 B USD | ||
| 859 |  TECH Bio-Techne Corp - Common Stock | 71.20 USD | -0.22% | +0.71% | +28.73% | +34.36% | 11.15 B USD | ||
| 876 |  ABVX Abivax SA - American Depositary Shares | 136.02 USD | +0.03% | -4.97% | +36.57% | +1411.33% | 10.68 B USD |